Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study comparing absorption of inhaled tanimilast (CHF 6001) in adolescent and adult asthma patients
BulgariaStudy on Long-Term Safety of Briquilimab for Patients with Chronic Urticaria
GermanyStudy on Early Switching to Dolutegravir and Lamivudine for Adults with HIV-1 on Three-Drug Regimen with Virological Suppression
ItalyStudy on the Safety and Tolerability of Norucholic Acid Tablets for Patients with Primary Sclerosing Cholangitis (PSC)
AustriaStudy on Avacopan with Rituximab or Cyclophosphamide for Children Aged 6 to 17 with Active ANCA-associated Vasculitis
BelgiumStudy on the Effects of Cladribine on Brain Cells in Patients with Multiple Sclerosis
FinlandStudy on Long-term Safety of XTMAB-16 for Patients with Pulmonary Sarcoidosis with or without Extra-pulmonary Involvement
CzechiaStudy on the Safety and Effectiveness of TolDec and Immunotherapy for Patients with Relapsing-Remitting Multiple Sclerosis
SpainStudy Comparing Weekly Islatravir/Lenacapavir Regimen to Standard Care in HIV Patients with Controlled Viral Load
GermanyStudy on Dolutegravir and Lamivudine for Maintaining Viral Control in Children with HIV Aged 2 to Under 15 Years
SpainStudy on the Effects of IDP-122 Lotion for Children with Moderate to Severe Plaque Psoriasis
PolandStudy on the Effects of Brepocitinib and Prednisone for Adults with Active Non-Infectious Uveitis
AustriaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
